• Plasma Discharge Degradation of Sulfamonomethoxine: Efficacy

  2026-06-05

  This study details the degradation of sulfamonomethoxine (SMM) in aqueous solution using pulsed plasma discharge, quantifying removal kinetics and identifying transient by-products. It highlights the method's efficiency and the unexpected ecotoxicity risk posed by hydrogen peroxide generated during treatment, with broad implications for environmental management of veterinary antibiotics.

• FLNa-Mediated NF-κB Inhibition Promotes HEV Replication: Mec

  2026-06-04

  This study uncovers how hepatitis E virus (HEV) exploits the downregulation of filamin A (FLNa) to block NF-κB signaling, enabling enhanced viral replication and immune evasion. The findings clarify a crucial cytoskeletal-immune interface in HEV pathogenesis, informing the design of future antiviral and inflammation-modulating research models.

• MLN4924 HCl Salt: Robust NEDD8-Activating Enzyme Inhibition

  2026-06-04

  This scenario-driven guide explores how MLN4924 HCl salt (SKU A3629) addresses real-world laboratory challenges in cell viability, proliferation, and cytotoxicity assays. Benchmarked by published data and validated workflows, this article empowers biomedical researchers and lab technicians to achieve reproducible, sensitive results using this selective NEDD8-activating enzyme inhibitor.

• Sulfachloropyridazine in Experimental Models: Insights Beyon

  2026-06-03

  Explore Sulfachloropyridazine as a sulfonamide antibacterial agent in advanced research. This article delivers a unique systems-level analysis of its role in microbial ecology, enzyme assays, and in vivo infection models, with actionable insights for protocol design.

• Nelfinavir Mesylate: Precision HIV-1 Protease Inhibition in

  2026-06-03

  Nelfinavir Mesylate stands out as a potent, orally bioavailable HIV-1 protease inhibitor, now redefining both antiviral workflows and protein homeostasis studies. Drawing from the latest insights in ferroptosis and the UPS, this guide details protocol enhancements, troubleshooting strategies, and cross-domain innovations for translational research.

• GPX4-Driven GSH Consumption and Platinum Resistance in Lung

  2026-06-02

  This study reveals that glutathione peroxidase 4 (GPX4)-dependent high glutathione (GSH) consumption underlies acquired resistance to platinum chemotherapy in lung cancer-derived brain metastases. The work clarifies a Wnt/NR2F2/GPX4 signaling axis that suppresses ferroptosis, offering mechanistic insights and potential intervention points for overcoming chemoresistance.

• Amorolfine Hydrochloride: Antifungal Reagent for Advanced Fu

  2026-06-02

  Amorolfine Hydrochloride enables precision studies on fungal membrane integrity and ploidy adaptation, standing out for its high purity and optimized solubility in DMSO and ethanol. This article demystifies applied workflows, troubleshooting, and protocol enhancements, translating the latest yeast cell integrity research into actionable strategies for antifungal resistance and cell physiology assays.

• Cy3 Goat Anti-Mouse IgG (H+L) Antibody: Practical Lab Use Gu

  2026-06-01

  The Cy3 Goat Anti-Mouse IgG (H+L) Antibody enables sensitive, fluorescent detection of mouse primary antibodies in immunofluorescence, flow cytometry, and western blotting. It is best suited for research workflows requiring reliable signal amplification and quantitative visualization of mouse IgG targets. This product is not optimized for diagnostic or clinical applications and should not be used outside research settings.

• EZ Cap™ mCherry mRNA (5mCTP, ψUTP): Enhanced Red Reporter mR

  2026-06-01

  EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is a red fluorescent protein mRNA engineered for high stability, translational efficiency, and minimal innate immune activation. Its Cap 1 structure and nucleotide modifications enable robust, reproducible fluorescent protein expression in diverse cell biology workflows.

• Primidone (Mysoline): Beyond Epilepsy—Mechanisms, Dosing, an

  2026-05-31

  Explore the multifaceted mechanisms of Primidone in research, including its dual activity as a TRPM3 and RIPK1 inhibitor. This article offers fresh perspectives on animal model dosing and cross-domain applications, setting it apart from existing Mysoline content.

• FPR2/ALX Agonism Restricts Autoimmune Astrocytopathy via Mic

  2026-05-30

  This study elucidates the therapeutic effect of FPR2/ALX stimulation using Quin-C1 in a mouse model of autoimmune astrocytopathy. By dissecting the roles of microglia and NK cells along the SYK-AKT axis, the findings suggest new immunomodulatory strategies for CNS demyelinating diseases like NMOSD.

• Deferoxamine Mesylate: Applied Workflows in Iron and Hypoxia

  2026-05-29

  Deferoxamine mesylate stands out as a powerful iron-chelating agent for dissecting iron metabolism, oxidative stress, and hypoxia pathways in both cancer and regenerative models. This guide combines advanced protocol tips, troubleshooting strategies, and insights from translational studies to help researchers harness the full potential of Deferoxamine mesylate from APExBIO in complex experimental setups.

• JHU-083: Unlocking Glutaminase Pathways for Translational Br

  2026-05-29

  Explore how JHU-083, a next-generation 6-diazo-5-oxo-L-norleucine precursor, is transforming glutaminase pathway research in neurological disease and experimental cerebral malaria. This article provides mechanistic insight, protocol guidance, and strategic context for translational researchers, while integrating the latest findings on glutathione metabolism and oxidative stress.

• Minocycline HCl in Retinal and Neuroinflammation Models

  2026-05-28

  Minocycline HCl bridges robust antimicrobial action with advanced anti-inflammatory and neuroprotective applications, enabling precise modulation of microglial activity in retinal and neurodegenerative disease research. Discover stepwise workflows, optimization strategies, and troubleshooting tips for integrating minocycline hydrochloride into high-impact experimental designs.

• Disulfiram: Proteasome Inhibition and Pyroptosis Modulation

  2026-05-28

  Disulfiram, a dopamine β-hydroxylase inhibitor, is redefining cancer and inflammasome research by combining potent proteasome inhibition with pyroptosis pathway modulation. This article delivers actionable experimental workflows, protocol enhancements, and troubleshooting strategies that maximize Disulfiram’s translational value across apoptosis and breast cancer models.

456 records 16/31 page Previous Next First page 上5页 1617181920 下5页 Last page